Red Arrow Therapeutics
Red Arrow Therapeutics Inc. develops pH-sensing nanomedicine drug delivery technologies for multiple therapeutic areas, including oncology. Emerging from the University of Tokyo's Cabral Lab, the company is committed to delivering cutting-edge technology for patients worldwide. Their lead compound is an IL-12-loaded nanopolymeric micelle.
Buy Funded Startups lists
Funding Round: Seed+
Funding Amount: $4.5M
Date: 23-Apr-2024
Investors: Beyond Next Ventures Inc., The University of Tokyo Edge Capital Partners Co., Ltd., Keio Innovation Initiative, Inc., OSAKA University Venture Capital Co., Ltd.
Markets: Nanomedicine, Drug Delivery, Oncology
HQ: Cambridge, Massachusetts, United States
Founded: 2021
Website: https://redarrowtx.com/
LinkedIn: https://www.linkedin.com/company/red-arrow-tx
Twitter: https://twitter.com/RedArrowTX
Leave a Comment
Comments
No comments yet.